Authors: Katherine Xiong, MD; Courtney J. Wusthoff, MD, MS
Division of Child Neurology, Stanford University
Reviewed: February 2022
SUMMARY
Ohtahara syndrome (OS) is a rare form of epilepsy that occurs in infants. It is also sometimes called:
- Early infantile epileptic encephalopathy (EIEE)
- EEIE with burst suppression pattern (EIEE-BS)
OS is one of a group of developmental epileptic encephalopathies (DEEs). DEEs are epilepsy syndromes that impact development at an early age. Children with Ohtahara syndrome typically develop seizures within the first weeks or months of life. These seizures can be hard to control. Children with OS also have developmental delays.
Ohtahara syndrome can have different kinds of causes:
- Structural abnormalities. Most often, OS is caused by differences in how the brain has developed before birth.
- Metabolic disorders. This is a less common cause of OS.
- Genetic mutations. This is a less common cause of OS.
JUMP TO
Disorder Overview
SIGNS AND SYMPTOMS
Children with Ohtahara syndrome have two primary symptoms:
- Seizures
- Developmental delays
Seizures
Timing
Children with Ohtahara syndrome develop frequent seizures within the first 3 months of life. They most commonly appear within the first 2 weeks after birth.
Severity
These seizures can be very difficult to control. They often require several antiseizure medications.
Types of Seizures
OS is associated with several different types of seizures.
An EEG or long-term video EEG monitoring is often very helpful to:
- Identify all the seizure types taking place
- Identify the frequency of the seizures
- Decide if an episode is a seizure or not
Tonic seizures are the most common type of seizure in those with OS. Tonic seizures are also known as tonic spasms. They usually last only a few seconds. They may:
- Look like stiffening of the arms and/or legs
- Affect one or both sides of the body
- Occur alone or in clusters
- Occur when a baby is awake or asleep
Other types of seizures that can occur in OS include:
- Focal seizures. Focal seizures start in one area of the brain. They can cause abnormal movements in just one part of the body.
- Atonic seizures. Atonic seizures are also called “drop attacks.” They cause children to suddenly lose muscle tone. This causes them to go limp.
- Myoclonic seizures. This involves brief, shock-like jerks of a muscle or group of muscles.
- Generalized tonic-clonic seizures. These are also called “grand mal” seizures. They affect both halves of the brain. They begin with a sudden loss of alertness. This is followed by muscle stiffness and jerking movements.
Development
Infants with Ohtahara syndrome have developmental delays. This can be the result of the underlying cause of their condition in combination with ongoing seizures. They often do not reach milestones at the same age as other infants. They may also have abnormal results on a neurological exam. For instance, they may be:
- Less active
- Less alert
- Prone to low muscle tone (hypotonia)
Developmental symptoms may be present before seizures start. However, they can worsen as the seizures increase.
CAUSES
Ohtahara syndrome can have several different causes.
- Brain malformations. Most cases of OS are due to abnormal brain development. These abnormalities can be:
- Diffuse. Affecting both sides of the brain. Most infants have diffuse brain abnormalities.
- Focal. Affecting only one area of the brain. This is less common.
- Genetic mutations. Genetic mutations can cause OS. This is because genetic differences can impact brain development or function.
- Metabolic disorders. Metabolic disorders can cause OS. They can impact how the body and brain use energy. This can lead to abnormal brain function and seizures.
Sometimes no clear cause is found, even after exams and testing. Cases in which there is no known cause are called idiopathic cases.
LABORATORY INVESTIGATIONS
Diagnosis
Ohtahara syndrome is usually diagnosed using:
- A clinical exam. A clinical history and exam are important. It can help identify signs and symptoms of OS. It should include details about any seizures.
- Electroencephalogram (EEG) or long-term video EEG monitoring (LTM). An EEG is a recording of brain activity. It is the most important test in making an OS diagnosis. An EEG in children with OS will show a certain pattern of brain activity. This pattern is called “burst suppression.” In burst suppression, there are periods of high-voltage abnormal brain activity (bursts) that alternate with periods of very little brain activity (suppression).
Additional Testing
Other testing can provide more information about the disorder and its cause.
- Magnetic resonance imaging (MRI). Images of a baby’s brain are not necessary for diagnosing OS. However, they can help doctors find an underlying cause. MRI is the best imaging for looking for structural changes in the brain.
- Laboratory tests. Some children require lab tests to identify cause of OS. This is especially true if an MRI is normal. Doctors may ask for:
- Genetic tests. There are three common types of genetic tests that can look for a cause of OS:
- Chromosomal microarrays
- Epilepsy genetic panels
- Whole exome sequencing
- Blood and urine tests. These can look for metabolic disorders.
- Genetic tests. There are three common types of genetic tests that can look for a cause of OS:
TREATMENT AND THERAPIES
Several treatments can be used to treat OS. The treatments are focused on controlling the seizures caused by OS.
Antiseizure medication
Epilepsy surgery
Focal seizures are seizures arising from one area of the brain. In these cases, surgery might be able to help reduce seizures. This can involve either:
- The removal of one area of the brain (a focal resection)
- The removal of most of one side of the brain (a hemispherectomy)
When epilepsy surgery is successful, it can lead to improved developmental outcomes for some children.
Ketogenic diet
Vagus nerve stimulation (VNS)
Correcting metabolic problems
OUTLOOK
There is no cure for Ohtahara syndrome. Treatment focuses on controlling seizures as much as possible and supporting development. Even with treatment, most children with OS will have seizures throughout their lifetime. Further, these seizures will be difficult to control.
Many children will have different types of seizures when they are older than they did when they were younger. Some will progress to having additional epilepsy syndromes, such as:
Some children will experience significant complications from OS or from its underlying cause. These children may die within the first two years of life.
Children who survive into childhood typically have severe physical and cognitive disabilities. They usually require a lot of assistance to perform the tasks of daily life. They may need help with eating or dressing. They may benefit from:
- Special educational support
- Physical and occupational therapy
- Speech and language therapy
Resources
Epilepsy Leadership Council
The Epilepsy Leadership Council is made up of individuals representing organizations serving individuals with epilepsy and their families, as well as professionals, and governmental organizations. The mission is to develop and coordinate among its members shared projects that will have a positive impact on the lives of individuals with epilepsy, focusing on those areas where working together produces greater efficiency and impact than working independently.
For a list of more than 40 professional societies, patient advocacy organizations, and governmental agencies, please click here.
Pediatric Epilepsy Surgery Alliance
The Pediatric Epilepsy Surgery Alliance (formerly known as The Brain Recovery Project) enhances the lives of children who need neurosurgery to treat medication-resistant epilepsy. They empower families with research, support services, and impactful programs before, during, and after surgery. PESA’s programs include research-based, reliable information to help parents and caregivers understand when a child’s seizures are drug-resistant; the risks and dangers of seizures; the pros and cons of the various neurosurgeries to treat epilepsy; the medical, cognitive, and behavioral challenges a child may have throughout life; school, financial aid, and life care issues. PESA’s resources include a comprehensive website with downloadable guides, pre-recorded webinars, and virtual workshops; an informative YouTube channel with comprehensive information about epilepsy surgery and its effects; a private Facebook group (Education After Pediatric Epilepsy Surgery) with over 300 members; Power Hour (bi-monthly open forums and live virtual workshops on various topics); and free school training to help your child’s education team understand the impact of their epilepsy surgery in school. Their Peer Support Program will connect you with a parent who has been there. The Pediatric Epilepsy Surgery Alliance also hosts biennial family conferences and regional events that allow families to learn from experts, connect with other families, and form lifelong friendships. They also provide a travel scholarship of up to $1,000 to families in need to fund travel to a level 4 epilepsy center for a surgical evaluation.
In addition, PESA has resources for medical professionals to assist in helping clinicians help the parents of their patients find the resources they need after surgery. Educators and therapists will also find helpful resources and information, including videos, guides, and relevant research. Patients who have undergone surgery are encouraged to register with the Global Pediatric Epilepsy Surgery Registry to help set future research priorities.
Child Neurology Foundation (CNF) solicits resources from the community to be included on this webpage through an application process. CNF reserves the right to remove entities at any time if information is deemed inappropriate or inconsistent with the mission, vision, and values of CNF.
Research
ClinicalTrials.gov for Ohtahara Syndrome (birth to 17 years)
These are clinical trials that are recruiting or will be recruiting. Updates are made daily, so you are encouraged to check back frequently.
ClinicalTrials.gov is a database of privately and publicly funded clinical studies conducted around the world. This is a resource provided by the U.S. National Library of Medicine (NLM), which is an institute within the National Institutes of Health (NIH). Listing a study does not mean it has been evaluated by the U.S. Federal Government. Please read the NLM disclaimer for details.
Before participating in a study, you are encouraged to talk to your health care provider and learn about the risks and potential benefits.
The information in the CNF Child Neurology Disorder Directory is not intended to provide diagnosis, treatment, or medical advice and should not be considered a substitute for advice from a healthcare professional. Content provided is for informational purposes only. CNF is not responsible for actions taken based on the information included on this webpage. Please consult with a physician or other healthcare professional regarding any medical or health related diagnosis or treatment options.
References
References:
1. Gürsoy S, Erçal D. Diagnostic Approach to Genetic Causes of Early-Onset Epileptic Encephalopathy. J Child Neurol. 2016 Mar 1;31(4):523–32. https://doi.org/10.1177/0883073815599262
2. Beal JC, Cherian K, Moshe SL. Early-Onset Epileptic Encephalopathies: Ohtahara Syndrome and Early Myoclonic Encephalopathy. Pediatric Neurology. 2012 Nov 1;47(5):317–23. https://doi.org/10.1016/j.pediatrneurol.2012.06.002
3. Ohtahara Syndrome [Internet]. Epilepsy Foundation. [cited 2021 Oct 4]. Available from: https://www.epilepsy.com/learn/types-epilepsy-syndromes/ohtahara-syndrome
4. Ohtahara Syndrome Information Page | National Institute of Neurological Disorders and Stroke [Internet]. [cited 2021 Oct 4]. Available from: https://www.ninds.nih.gov/Disorders/All-Disorders/Ohtahara-Syndrome-Information-Page
5. Pavone P, Spalice A, Polizzi A, Parisi P, Ruggieri M. Ohtahara syndrome with emphasis on recent genetic discovery. Brain and Development. 2012 Jun 1;34(6):459–68. https://doi.org/10.1016/j.braindev.2011.09.004
6. Yamamoto H, Okumura A, Fukuda M. Epilepsies and epileptic syndromes starting in the neonatal period. Brain and Development. 2011 Mar;33(3):213–20. https://doi.org/10.1016/j.braindev.2010.10.009